GLP-1 receptor agonists, the class of drugs that includes semaglutide, liraglutide and tirzepatide, have become one of the most commercially...
Read moreDetailsThe UAE's longevity and biohacking market is booming. Peptide therapies, IV infusions, biological-age tests, supplement stacks, full-body scans, wearables and...
Read moreDetailsPureHealth has retained its position as the UAE's leading healthcare brand portfolio in Brand Finance's UAE 50 and Middle East...
Read moreDetailsThe GCC pharmaceutical market exceeded $30 billion in 2025, according to a new JLL report, as Saudi Arabia and the...
Read moreDetailsIn a truly vital move for global disaster response and conflict resolution, TRENDS Barometer has officially signed a Memorandum of...
Read moreDetailsIn a stellar showcase of financial resilience and operational efficiency, Agthia Group PJSC has unveiled its spectacular first-half and second-quarter...
Read moreDetailsThe UAE longevity economy 2026 is one of the most significant commercial opportunities in the country that most businesses are...
Read moreDetailsThe Women and Children's Hospital at Sheikh Khalifa Medical City – Ajman achieves the esteemed Centre of Excellence status, marking...
Read moreDetailsI want to make a distinction that I think is important and often glossed over. Wellness is not the same...
Read moreDetailsIn a powerful move to ensure the absolute safety of its citizens and residents, Abu Dhabi has officially launched the...
Read moreDetails© 2025 | Moguls Middle East | All Rights Reserved | Developed By BlessHost